https://ir.castlebiosciences.com/news-events/press-releases/rss en-us https://d1io3yog0oux5.cloudfront.net/castlebiosciences/files/theme/images/logo-sm.png Equisolve Investor Relations Suite https://ir.castlebiosciences.com/news-events/press-releases/detail/488/castle-biosciences-to-participate-in-upcoming-investor-conferences Wed, 28 Oct 26 07:00:00 -0400 https://ir.castlebiosciences.com/news-events/press-releases/detail/488/castle-biosciences-to-participate-in-upcoming-investor-conferences https://ir.castlebiosciences.com/news-events/press-releases/detail/487/castle-biosciences-to-release-third-quarter-2026-financial-results-and-host-webcast-on-thursday-nov-5-2026 Thu, 15 Oct 26 07:00:00 -0400 https://ir.castlebiosciences.com/news-events/press-releases/detail/487/castle-biosciences-to-release-third-quarter-2026-financial-results-and-host-webcast-on-thursday-nov-5-2026 https://ir.castlebiosciences.com/news-events/press-releases/detail/486/acg-2026-data-show-tissuecypher-identifies-elevated-risk-of-progression-beyond-pathology-findings-in-barretts-esophagus Mon, 12 Oct 26 16:30:00 -0400 https://ir.castlebiosciences.com/news-events/press-releases/detail/486/acg-2026-data-show-tissuecypher-identifies-elevated-risk-of-progression-beyond-pathology-findings-in-barretts-esophagus https://ir.castlebiosciences.com/news-events/press-releases/detail/485/late-breaking-eadv-2026-data-support-use-of-decisiondx-melanoma-in-slnb-decision-making-and-risk-aligned-post-surgical-management Wed, 30 Sep 26 16:30:00 -0400 https://ir.castlebiosciences.com/news-events/press-releases/detail/485/late-breaking-eadv-2026-data-support-use-of-decisiondx-melanoma-in-slnb-decision-making-and-risk-aligned-post-surgical-management https://ir.castlebiosciences.com/news-events/press-releases/detail/484/new-study-shows-that-tissuecypher-changed-management-at-an-expert-surgery-center-in-90-of-patients-with-non-dysplastic-barretts-esophagus Mon, 28 Sep 26 07:00:00 -0400 https://ir.castlebiosciences.com/news-events/press-releases/detail/484/new-study-shows-that-tissuecypher-changed-management-at-an-expert-surgery-center-in-90-of-patients-with-non-dysplastic-barretts-esophagus https://ir.castlebiosciences.com/news-events/press-releases/detail/483/new-study-highlights-clinical-need-for-molecular-guidance-in-atopic-dermatitis-treatment-selection-reinforcing-the-value-of-advancead-tx Thu, 24 Sep 26 16:30:00 -0400 https://ir.castlebiosciences.com/news-events/press-releases/detail/483/new-study-highlights-clinical-need-for-molecular-guidance-in-atopic-dermatitis-treatment-selection-reinforcing-the-value-of-advancead-tx https://ir.castlebiosciences.com/news-events/press-releases/detail/482/castle-biosciences-to-open-new-laboratory-facility-in-scottsdale Tue, 22 Sep 26 07:00:00 -0400 https://ir.castlebiosciences.com/news-events/press-releases/detail/482/castle-biosciences-to-open-new-laboratory-facility-in-scottsdale https://ir.castlebiosciences.com/news-events/press-releases/detail/481/new-decision-modeling-study-demonstrates-tissuecypher-significantly-improves-risk-aligned-management-for-patients-with-barretts-esophagus Tue, 15 Sep 26 07:00:00 -0400 https://ir.castlebiosciences.com/news-events/press-releases/detail/481/new-decision-modeling-study-demonstrates-tissuecypher-significantly-improves-risk-aligned-management-for-patients-with-barretts-esophagus https://ir.castlebiosciences.com/news-events/press-releases/detail/480/jaad-publication-shows-improved-performance-of-decisiondx-scc Wed, 09 Sep 26 16:30:00 -0400 https://ir.castlebiosciences.com/news-events/press-releases/detail/480/jaad-publication-shows-improved-performance-of-decisiondx-scc https://ir.castlebiosciences.com/news-events/press-releases/detail/479/castle-biosciences-to-participate-in-upcoming-investor-conferences Thu, 20 Aug 26 07:00:00 -0400 https://ir.castlebiosciences.com/news-events/press-releases/detail/479/castle-biosciences-to-participate-in-upcoming-investor-conferences